Rajaie Batniji, MD, PhD, Afia Asamoah, JD, and Sanjay Basu, MD, PhD, cofounders of Waymark, join Vineeta Agarwala, MD, PhD, a16z Bio + Health general partner, to discuss their transformative approach to Medicaid care delivery. This episode dives into their rising risk signal prediction framework, where cutting-edge machine learning predicts patient needs and enables community-based care teams to reduce preventable ER visits and improve health outcomes at scale. The team recently published their real-world results—including a 23% reduction in unnecessary acute care—in the New England Journal of Medicine Catalyst. Additional resources: - Supporting Rising-Risk Medicaid Patients Through Early Intervention, NEJM Catalyst: https://catalyst.nejm.org/doi/abs/10.1056/CAT.24.0060 - The Body Economic: Why Austerity Kills, by David Stuckler and Sanjay Basu: https://www.hachettebookgroup.com/titles/david-stuckler/the-body-economic/9780465063987/?lens=basic-books Plus: Find Vineeta on X: https://x.com/vintweeta Learn more about a16z Bio+Health: https://a16z.com/bio-health/ Learn more about Raising Health: https://a16z.com/podcasts/raising-health/ Stay Updated: Find a16z Bio+Health on LinkedIn: https://www.linkedin.com/showcase/a16z-bio-health/ Find a16z Bio+Health on X: https://x.com/a16zBioHealth Subscribe on your favorite podcast app: https://a16z.com/podcasts/raising-health/ Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.